Clinical Trials Logo

Exercise Capacity clinical trials

View clinical trials related to Exercise Capacity.

Filter by:

NCT ID: NCT04021342 Completed - Cognitive Function Clinical Trials

The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Physiological and Cognitive Function

Start date: October 12, 2018
Phase: N/A
Study type: Interventional

A randomized, double blind, counterbalanced, placebo controlled independent groups design to determine the effects of 3 month supplementation with tart cherry concentrate on indices of cardiometabolic health, exercise capacity and cognitive function. Following screening and recruitment, participants are familiarised with the testing equipment and procedures after which they will be randomly assigned to receive either Montmorency tart cherry concentrate (MC) or an isocaloric placebo (PLA), stratified by gender. The study is comprised of two experimental visits and outcome variables are assessed at baseline (before supplementation) and at 3 months (follow up; after supplementation).

NCT ID: NCT03940911 Not yet recruiting - Fatigue Clinical Trials

Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis

Famuspa
Start date: September 17, 2024
Phase: N/A
Study type: Interventional

Axial spondyloarthropathy (SpA) is the most common inflammatory rheumatism (1% of the general population) with important medico-economic consequences. Fatigue is a major feature of SA. It can be defined as a feeling of reduced muscle capacity, lack of energy and exhaustion. The fatigue reaches an abnormally high level (fatigue severity score (FSS) ≥4, called severe fatigue in this protocol) in more than two thirds of patients with SA. Skeletal muscle repercussions are present during SA. It is characterized by a decrease in exercise capacity independently of pain and ankylosis but is associated with a decrease in strength and muscle mass, the importance of which varies from one study to another. The link between fatigue (subjective sensation) and the skeletal muscular impact (objective) of SA has never been studied.

NCT ID: NCT03887117 Completed - Smoking Clinical Trials

Effect of Switching From Cigarette Smoking to IQOS on Exercise Capacity

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This exploratory study is part of the global clinical assessment program of IQOS. It was designed to provide scientific evidence to further substantiate the reduced risk potential of using a heated tobacco product (the Tobacco Heating System [THS] marketed as IQOS) as compared to smoking cigarettes. The main goals of this exploratory study were to assess whether switching from cigarette smoking to using IQOS would influence 1) maximum oxygen uptake during incremental exercise (VO2max) and exercise capacity, 2) ability to perform exercise training and thereby influence 3) VO2max after 12 weeks of exercise training, 4) physiological parameters and biological health markers, and finally 5) physical activity levels in daily life.

NCT ID: NCT03799263 Active, not recruiting - COPD Clinical Trials

A Six Minute Walking Test Based Index as an Outcome Predictor in COPD Subjects. (Chronic Obstructive Pulmonary Disease)

COPD
Start date: February 1, 2019
Phase:
Study type: Observational

The six minute walking test (6MWT) is a recognized clinical test to evaluate exercise capacity in different diseases and different conditions. The modalities of performance are described in International Guidelines. The usually reported measure is the distance in meters walked in 6 minutes. Despite the report of a single variable during the test is considered as a limit, changes in monitored variables are seldom analyzed together with the distance walked. In the past there have been some attempts of multifactorial evaluation of 6MWT, however up to date, there is no system considering together the changes of different variables. The investigators wonder whether a multidimensional index based on variables monitored during the 6MWT would better predict 24 month exacerbations and mortality in COPD patients.

NCT ID: NCT03793647 Recruiting - Clinical trials for Congestive Heart Failure

Electrical Muscle Stimulation in Congestive Heart Failure

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This trial is to evaluate two types of electrical muscle Stimulation (EMS) stimulation (low intensity "conventional stimulation" vs. high intensity "Russian" stimulation) of legs in comparison with a control group without EMS in a cohort of elderly patients with severe deconditioning after CHF decompensation.

NCT ID: NCT03531138 Completed - Clinical trials for Pulmonary Rehabilitation

Is it Possible to Use the Timed Performance Tests in Lung Transplantation Candidates to Determine the Exercise Capacity?

Start date: May 20, 2018
Phase: N/A
Study type: Interventional

Lung transplantation candidates will be performed a 3-month hospital-based preoperative exercise training. A 6-minute walk test, a 10-meter walking speed test and a 5-times sit to stand test will be performed to determine the exercise capacity of the patient. The tests will be carried out at the beginning and end of rehabilitation. At each testing session, the tests will be performed sequentially by the same physiotherapist, giving 20 minute rest periods within the same day. It will be analyzed how the test data correlate with each other and how the delta values calculated for each test reflect the rehabilitation outcomes calculated after the exercise program.

NCT ID: NCT03514823 Completed - Blood Pressure Clinical Trials

Respiratory Muscle Contribution to Blood Pressure During Exercise

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

The investigators seek to understand how reflexes from the breathing muscles influence blood pressure during exercise. Furthermore, the investigators are determining if increasing breathing muscle strength (via inspiratory muscle training) influences the respiratory muscle contribution to blood pressure during exercise.

NCT ID: NCT02575469 Not yet recruiting - Exercise Capacity Clinical Trials

Exercise Capacity in Diseases and Health

Start date: October 1, 2017
Phase: N/A
Study type: Observational

Exercise capacity is a key factor to evaluate and treat patients in different diseases (e.g. ischemic heart disease, chronic obstructive pulmonary disease, cystic fibrosis). The best way to measure exercise capacity is to perform a cardiopulmonary exercise testing. Normal/reference values in health and disease relate to specific population and subpopulations. The population in Israel is unique in its diversity. Objectives: Data collection of exercise capacity assessment in health and illness in the northern of Israel for future local database. Population: 500 Patients evaluated routinely in the exercise lab (pediatric cardiology institute) and healthy volunteers evaluated as controls. Study design: Prospective observational study. Participants will answer a health related questioner, undergo a physical examination, perform a cardiopulmonary exercise test on a treadmill or a cycle ergometer.

NCT ID: NCT02493114 Recruiting - Lung Cancer Clinical Trials

Physical Functioning Throughout Lung Cancer Treatment

LUCAT
Start date: July 2015
Phase:
Study type: Observational

This trial investigates the impact of lung cancer treatment on physical status, symptoms and quality of life. Furthermore this trial investigates possible underlying causes and consequences of deconditioning.

NCT ID: NCT01259739 Completed - Exercise Capacity Clinical Trials

Cocoa Flavanols and Exercise Capacity

Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to characterize the potential improvement of cocoa flavanols on exercise capacity in highly trained cyclist. A placebo-controlled double-blinded randomized control study will be performed in 13 highly trained cyclist (crossover design). Participants will perform a baseline exercise testing on an ergometer. They will receive either a flavanol-poor or flavanol rich cocoa drink twice daily for one week before a second and third exercise testing is performed. The order of drinks is randomized and balanced (high-flavanol-->low-flavanol drink or low-flavanol drink-->high-flavanol drink)